SCHEMBL19230550

SCHEMBL19230550

CC[C@@H]1Cc2ccccc2CO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
NPY1R P25929 1/20 0.43
CASP1 P29466 1/20 0.43
NPY2R P49146 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
DRD3 P35462 1/20 0.40
LMNA P02545 2/20 0.40
SIGMAR1 Q99720 1/20 0.38
HTR1A P08908 1/20 0.35
CYP2D6 P10635 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14077115 1.00 HTT (0.44) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL4157891 0.80 MEN1 (0.43) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL27931200 0.79 MEN1 (0.40) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL12601225 0.77 DRD3 (0.35) DRD3SIGMAR1HTR1A
SCHEMBL16684513 0.76 ALDH1A1 (0.40) HTTMEN1KMT2AALDH1A1MAPT
SCHEMBL15319634 0.75 HTT (0.35) HTTALDH1A1HPGDTSHRHSD17B10
SCHEMBL17150851 0.72 NPC1 (0.40) HTTMEN1KMT2ANPC1RAB9A
SCHEMBL19230495 0.72 NPC1 (0.40) HTTMEN1KMT2ANPC1RAB9A
SCHEMBL21576151 0.72 NPC1 (0.40) HTTMEN1KMT2ANPC1RAB9A
SCHEMBL434338 0.72 HRH3 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023027948-A1 JAK2 INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed
WO-2017133521-A1 FXR RECEPTOR AGONIST 山东轩竹医药科技有限公司 2017-08-10 WO disclosed